Nautilus Biotechnology, Inc. (NAUT)

NASDAQ: NAUT · IEX Real-Time Price · USD

2.610

-0.090 (-3.33%)

At close: Jul 19, 2024, 12:00 AM

2.600

-0.010 (-0.38%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Nautilus Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-67.44	-63.68	-57.92	-50.32	-15.62	-9.62
Depreciation & Amortization	6.13	5.71	3.42	2.84	2.35	0.55
Share-Based Compensation	12.39	12.14	10.38	7.93	0.37	0.11
Other Operating Activities	-6.53	-5.88	-1.68	0.3	-1.09	-0.7
Operating Cash Flow	-55.45	-51.71	-45.81	-39.24	-14	-9.66
Capital Expenditures	-2.4	-2.44	-2.32	-2.27	-0.92	-0.93
Change in Investments	-5.49	-41.29	-23.42	-136.7	-24.36	4.98
Investing Cash Flow	-7.89	-43.74	-25.74	-138.96	-25.28	4.05
Share Issuance / Repurchase	0.61	0.37	0.56	335.58	0.04	0.04
Other Financing Activities	-	-	-	-8.13	75.86	-
Financing Cash Flow	0.61	0.37	0.56	327.45	75.9	0.04
Net Cash Flow	-62.73	-95.08	-70.98	149.24	36.62	-5.58
Free Cash Flow	-57.85	-54.15	-48.13	-41.51	-14.92	-10.59
Free Cash Flow Per Share	-0.46	-0.43	-0.39	-0.49	-0.51	-1.75

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).